Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance GlobeNewswire October 28, 2025 Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchises Orders increased sequentially and greater than 20% year-over-year Increasing revenue guidance to a range of $729 to […]
Context Therapeutics to Participate in Upcoming Investor Conferences GlobeNewswire October 28, 2025 PHILADELPHIA, Oct. 28, 2025 (GLOBE NEWSWIRE) — Context Therapeutics Inc. (“Context” or the “Company”) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in two upcoming investor conferences. Upcoming Investor Conferences Guggenheim 2nd
Purpose Investments Inc. Announces Final October 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund GlobeNewswire October 28, 2025 TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) — Purpose Investments Inc. announced today the final October 2025 distribution rates for Purpose High Interest
Lantronix Edge AI Technology Powers Sightline's New AI-Driven Video Processor for Mission-Critical Drone Applications Strategic Collaboration positions Lantronix for long-term opportunities in the global drone market GlobeNewswire October 28, 2025 IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications,
Dynacor Group Declares November 2025 Dividend GlobeNewswire October 28, 2025 MONTREAL, Oct. 28, 2025 (GLOBE NEWSWIRE) — Dynacor Group Inc. (TSX: DNG) (“Dynacor“ or the “Corporation“) announced its monthly dividend payment for November 2025 in the amount of C$0.01333 per common share which will be payable on November 19, 2025, to shareholders of record as
Midland Continues to Discover New Gold Mineralization at the Caniapisc Au Project, James Bay GlobeNewswire October 28, 2025 MONTREAL, Oct. 28, 2025 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce gold results from the September follow-up exploration program on the new discovery of gold, zinc, and silver on its Caniapisc
Kiniksa Pharmaceuticals Reports Third Quarter 2025 Financial Results and Recent Portfolio Execution GlobeNewswire October 28, 2025 – ARCALYST(R) (rilonacept) Q3 2025 net product revenue of $180.9 million, representing 61% year-over-year growth –– ARCALYST 2025 expected net product revenue raised to $670 – $675 million –– KPL-387 granted Orphan Drug Designation for the treatment of pericarditis
Hubbell Reports Third Quarter 2025 Results GlobeNewswire October 28, 2025 Shelton, CT, Oct. 28, 2025 (GLOBE NEWSWIRE) — HUBBELL REPORTS THIRD QUARTER 2025 RESULTS 3Q diluted EPS of $4.77; adjusted diluted EPS of $5.17 3Q net sales +4% (organic +3%) 3Q operating margin 22.0%; adjusted operating margin 23.9% Raising 2025 diluted EPS outlook to $16.55-$16.75;
Cronos Brings Back Popular, Limited-Edition Spinach(R) Green Apple-Flavored Products for the Fall Season GlobeNewswire October 28, 2025 TORONTO, Oct. 28, 2025 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”), an innovative global cannabinoid company, announced today that it is welcoming back its limited-edition Caramel Green Apple flavor to its best-selling lineup of
NEW YORK, NY / ACCESS Newswire / October 28, 2025 / If you suffered a loss on your MoonLake Immunotherapeutics (NASDAQ:MLTX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/moonlake-lawsuit-submission-form?prid=174282&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call